How repurposing a drug in a COVID-19 trial could benefit people with cancer
People with cancer have been severely affected by COVID-19, with the pandemic impacting how they're diagnosed, treated and cared for.
Mar 3, 2021
0
0
People with cancer have been severely affected by COVID-19, with the pandemic impacting how they're diagnosed, treated and cared for.
Mar 3, 2021
0
0
Cancer is the second leading cause of death in the world. The number of deaths and incidences is increasing each year. The metal-based anticancer drugs were used clinically worldwide, but suffer from poor selectivity, serious ...
Jan 25, 2021
0
4
Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have biofabricated human colorectal cancer miniature organs, called organoids, to better understand how a tumor grows in its natural microenvironment ...
Aug 5, 2020
0
63
A newly discovered mechanism at work in human immunodeficiency virus (HIV) patients may also lead to new treatments for COVID-19, according to a team of researchers at the University of Alberta.
Jul 31, 2020
0
928
Normally, the immune system is able to differentiate between healthy and abnormal cells. Peptides, fragments created by the synthesis and breakdown of proteins inside each cell, are presented on the surface as antigens and ...
Jun 2, 2020
0
79
Cancer Research UK and its partners have today launched a clinical trial to test if a drug that's used to treat inflammation of the pancreas can help people with COVID-19.
Jun 1, 2020
0
1
Senescence is a response to cell damage and stress characterized by the arrest of the cell cycle. When aging, cells permanently stop dividing, thus preventing the propagation of damaged and dysfunctional cells. However, eventually, ...
May 5, 2020
0
14
More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a radical idea: What if he could unlock the therapeutic potential of ancient Chinese medicines ...
Mar 16, 2020
0
38
Cancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer.
Dec 19, 2019
0
598
When prostate cancer spreads, it most often spreads to bone. And while the 5-year survival rate for prostate cancer that has not spread is nearly 100 percent, once the disease reaches bone, the 5-year survival rate is only ...
Dec 2, 2019
0
2